Please find a link to our recent paper discussing new technologies for
manufacturing vaccines, diagnostic reagents and other clinical products with
potential application in Africa.
New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs
BY ELUEMUNO R. BLYDEN, PHD , PETER K. WATLER, PHD
Recombinant vector technologies can improve the yield and lower the cost of
egg-based influenza vaccine production.
BioPharm International Supplements
Dr. Eluemuno R. Blyden